Newlife Capital
VC Fund
Beijing, China
Newlife Capital is a VC fund in Beijing focused on Biotechnology and Medical. Newley Capital is an investment and fund management platform that leverages top domestic and international industry resources and long-term capital. It operates across fund of funds, direct investment, and private equity secondary share investments, utilizing both domestic RMB and overseas US dollars. The platform focuses on sectors likehealthcare, semiconductors and intelligent manufacturing, new energy and carbon neutrality, and consumer technology.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Newlife Capital invests in
Stages Newlife Capital invests in
Countries Newlife Capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Deng Shuang
|
|||
Lin Xianghong
|
|||
Investment Focus
Industry
- Biotechnology 2 (33%)
- Medical 1 (17%)
- Data Center 1 (17%)
- Health Care 1 (17%)
- Therapeutics 1 (17%)
Stage
- Seed 2 (33%)
- Series A 2 (33%)
- Series B 1 (17%)
Country
- China 3 (50%)
- United States 2 (33%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Deng Shuang
Founding Partner
|
Founding Partner | Total investments: 0 | Find email | |
|
Lin Xianghong
Founding Partner
|
Founding Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Aureka Biotechnologies
|
Aureka Biotechnologies is a pioneering biotech firm dedicated to democratizing the pharmaceutical sector in order to conquer sickness. | $35M / Series A / Apr 28, 2026 | |
Yipuji
|
Yipuji provides modular data center infrastructure products and integrated engineering services that support the planning, design, prefabrication, and deployment of scalable data center facilities. The company’s portfolio includes prefabricated (modular) data center solutions such as all-in-one systems, flatpack edge modules, liquid-cooling modulestailored for high-performance computing, and functional modular components that help streamline construction workflows. It combines research, development, manufacturing, and technical service capabilities to deliver standardized yet customizable modules that aim to shorten build cycles and support technical teams in meeting project specifications. Yipuji also engages in product innovation and collaborates with technology partners to develop solutions for emerging needs like AI data centers and energy-efficient thermal management. The business integrates prefabrication with on-site delivery coordination, technical support resources, and engineering services to assist customers from design through implementation. Its activities include engineering research, ongoing technical support, and collaborations with academic and industry organizations to advance modular data center technologies. | $100M / Series B / Jan 23, 2026 | |
|
Revelyx
|
Revelyx Bio is a clinical-stage biotechnology business that specializes in novel botulinum toxin therapies. | Series A / Jan 09, 2026 | |
|
Inruidi
|
Inruidi is a medical technology service provider specializing in the sales of high-quality medical devices and the provision of comprehensive technical services. With a strong commitment to innovation and customer support, the company offers tailored solutions to healthcare institutions, ensuring reliable performance, regulatory compliance, andoptimal integration of advanced medical technologies into clinical practice. | Seed / Oct 16, 2025 | |
|
Aureka Biotechnologies
|
Aureka Biotechnologies is a pioneering biotech firm dedicated to democratizing the pharmaceutical sector in order to conquer sickness. | $23.4M / Series A / Sep 26, 2025 | |
|
Jinling Biopharma
|
Jinling Bio is a company specializing in medical research and experimental development, focusing on medical technology innovation and related services. | Seed / Sep 08, 2025 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Newlife Capital invest in?
Newlife Capital invests primarily in Biotechnology, Medical and Data Center startups, most often at Seed and Series A stage. Most of the 6 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Newlife Capital?
Public channels for Newlife Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Newlife Capital?
The team at Newlife Capital includes Deng Shuang (Founding Partner) and Lin Xianghong (Founding Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
